1 year return (CAGR)
-38.44%
Neurobo Pharmaceuticals Inc Exchange (NASDAQ, USD)
NRBO
-
-0.09 (-4.55%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-81.12%
5 year return (CAGR)
-75.09%
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
16.28M
Price/Sales
4071.06
Ent value
3.81M
Price/Book
1.26
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-81.13%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
No data
Stock price data
| Open | 2.00 |
| Daily high | 2.00 |
| Daily low | 1.75 |
| Daily Volume | 23K |
| 1y analyst estimate | 26.67 |
| Beta | -0.28 |
| EPS (TTM) | -2.72 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| NRBO | S&P500 | |
| Current price drop from All-time high | -100.00% | -1.30% |
| Highest price drop | -100.00% | -56.47% |
| Date of highest drop | 24 Dec 2024 | 9 Mar 2009 |
| Avg drop from high | -85.03% | -10.68% |
| Avg time to new high | 97 days | 12 days |
| Max time to new high | 1886 days | 1805 days |
News
No items found